210 related articles for article (PubMed ID: 20427267)
1. Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice.
Prakash H; Albrecht M; Becker D; Kuhlmann T; Rudel T
J Biol Chem; 2010 Jun; 285(26):20291-302. PubMed ID: 20427267
[TBL] [Abstract][Full Text] [Related]
2. Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma.
Rothfuchs AG; Kreuger MR; Wigzell H; Rottenberg ME
J Immunol; 2004 Feb; 172(4):2407-15. PubMed ID: 14764711
[TBL] [Abstract][Full Text] [Related]
3. cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.
Prakash H; Becker D; Böhme L; Albert L; Witzenrath M; Rosseau S; Meyer TF; Rudel T
PLoS One; 2009 Aug; 4(8):e6519. PubMed ID: 19657383
[TBL] [Abstract][Full Text] [Related]
4. The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism.
He X; Berland R; Mekasha S; Christensen TG; Alroy J; Kramnik I; Ingalls RR
PLoS Pathog; 2013; 9(8):e1003569. PubMed ID: 24009502
[TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
Caligiuri G; Rottenberg M; Nicoletti A; Wigzell H; Hansson GK
Circulation; 2001 Jun; 103(23):2834-8. PubMed ID: 11401941
[TBL] [Abstract][Full Text] [Related]
6. Chlamydophila pneumoniae downregulates MHC-class II expression by two cell type-specific mechanisms.
Peschel G; Kernschmidt L; Cirl C; Wantia N; Ertl T; Dürr S; Wagner H; Miethke T; Rodríguez N
Mol Microbiol; 2010 May; 76(3):648-61. PubMed ID: 20233301
[TBL] [Abstract][Full Text] [Related]
7. MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia.
Naiki Y; Michelsen KS; Schröder NW; Alsabeh R; Slepenkin A; Zhang W; Chen S; Wei B; Bulut Y; Wong MH; Peterson EM; Arditi M
J Biol Chem; 2005 Aug; 280(32):29242-9. PubMed ID: 15964841
[TBL] [Abstract][Full Text] [Related]
8. The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection.
Shimada K; Chen S; Dempsey PW; Sorrentino R; Alsabeh R; Slepenkin AV; Peterson E; Doherty TM; Underhill D; Crother TR; Arditi M
PLoS Pathog; 2009 Apr; 5(4):e1000379. PubMed ID: 19360122
[TBL] [Abstract][Full Text] [Related]
9. Loss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils.
Wicki S; Gurzeler U; Wei-Lynn Wong W; Jost PJ; Bachmann D; Kaufmann T
Cell Death Dis; 2016 Oct; 7(10):e2422. PubMed ID: 27735938
[TBL] [Abstract][Full Text] [Related]
10. M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae.
Buchacher T; Ohradanova-Repic A; Stockinger H; Fischer MB; Weber V
PLoS One; 2015; 10(11):e0143593. PubMed ID: 26606059
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.
Tvinnereim A; Wizel B
J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832
[TBL] [Abstract][Full Text] [Related]
12. Increased inflammation and impaired resistance to Chlamydophila pneumoniae infection in Dusp1(-/-) mice: critical role of IL-6.
Rodriguez N; Dietrich H; Mossbrugger I; Weintz G; Scheller J; Hammer M; Quintanilla-Martinez L; Rose-John S; Miethke T; Lang R
J Leukoc Biol; 2010 Sep; 88(3):579-87. PubMed ID: 20483921
[TBL] [Abstract][Full Text] [Related]
13. Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen.
Wizel B; Starcher BC; Samten B; Chroneos Z; Barnes PF; Dzuris J; Higashimoto Y; Appella E; Sette A
J Immunol; 2002 Sep; 169(5):2524-35. PubMed ID: 12193722
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors 2 and 4 do not contribute to clearance of Chlamydophila pneumoniae in mice, but are necessary for the release of monokines.
Mueller M; Postius S; Thimm JG; Gueinzius K; Muehldorfer I; Hermann C
Immunobiology; 2004; 209(8):599-608. PubMed ID: 15638128
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphocyte CD3 expression by Chlamydophila pneumoniae infection.
Yamaguchi H; Matsuo J; Sugimoto S; Utsumi M; Yamamoto Y
Microb Pathog; 2008 Oct; 45(4):290-6. PubMed ID: 18674609
[TBL] [Abstract][Full Text] [Related]
16. Induction of iNOS by Chlamydophila pneumoniae requires MyD88-dependent activation of JNK.
Rodriguez N; Lang R; Wantia N; Cirl C; Ertl T; Dürr S; Wagner H; Miethke T
J Leukoc Biol; 2008 Dec; 84(6):1585-93. PubMed ID: 18799752
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors 2 and 4 regulate the frequency of IFNγ-producing CD4+ T-cells during pulmonary infection with Chlamydia pneumoniae.
Wantia N; Rodriguez N; Cirl C; Ertl T; Dürr S; Layland LE; Wagner H; Miethke T
PLoS One; 2011; 6(11):e26101. PubMed ID: 22096480
[TBL] [Abstract][Full Text] [Related]
18. Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.
Rottenberg ME; Gigliotti Rothfuchs AC; Gigliotti D; Svanholm C; Bandholtz L; Wigzell H
J Immunol; 1999 Mar; 162(5):2829-36. PubMed ID: 10072530
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor superfamily members 1a and 1b contribute to exacerbation of atherosclerosis by Chlamydia pneumoniae in mice.
Zafiratos MT; Cottrell JT; Manam S; Henderson KK; Ramsey KH; Murthy AK
Microbes Infect; 2019 Mar; 21(2):104-108. PubMed ID: 30292879
[TBL] [Abstract][Full Text] [Related]
20. SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.
Yang T; Stark P; Janik K; Wigzell H; Rottenberg ME
J Immunol; 2008 Mar; 180(6):4040-9. PubMed ID: 18322213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
